Skip to content

PERSPECTIVE THERAPEUTICS, INC.: 10-K filed 2016-09-09

What PERSPECTIVE THERAPEUTICS, INC. reported in its annual report filed 2016-09-09 (fiscal FY 2016): 33 published measures, 105 facts as tagged in accession 0001144204-16-123313.

This filing

Form
10-K (annual report)
Filed
2016-09-09
Fiscal period
fiscal FY 2016
Accession
0001144204-16-123313 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All PERSPECTIVE THERAPEUTICS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2016-06-3018,101,850USD
At 2015-06-3023,003,284USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2016-06-301,700,797USD
At 2015-06-302,221,043USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2016-06-3016,401,053USD
At 2015-06-3020,782,241USD
At 2014-06-3023,955,768USD
At 2013-06-305,366,246USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2016-06-3010,139,026USD
At 2015-06-305,226,740USD
At 2014-06-307,680,073USD
At 2013-06-302,899,927USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2016-04-01 to 2016-06-30-1,184,813USD91
2015-07-01 to 2016-06-30-4,710,808USD366
2016-01-01 to 2016-03-31-1,195,297USD91
2015-10-01 to 2015-12-31-1,311,588USD92
2015-07-01 to 2015-09-30-1,019,110USD92
2015-04-01 to 2015-06-30-1,034,682USD91
2014-07-01 to 2015-06-30-3,681,051USD365
2015-01-01 to 2015-03-31-953,553USD90
2014-10-01 to 2014-12-31-906,954USD92
2014-07-01 to 2014-09-30-785,862USD92
2013-07-01 to 2014-06-30-5,959,122USD365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2015-07-01 to 2016-06-30479,215USD366
2014-07-01 to 2015-06-30133,305USD365
2013-07-01 to 2014-06-3019,029USD365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2016-06-30-66,442,315USD
At 2015-06-30-61,731,507USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2015-07-01 to 2016-06-300USD366
2014-07-01 to 2015-06-300USD365
2013-07-01 to 2014-06-300USD365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2016-06-30576,692USD
At 2015-06-30574,840USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2015-07-01 to 2016-06-30290,312USD366
2014-07-01 to 2015-06-30205,264USD365
2013-07-01 to 2014-06-30185,987USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2015-07-01 to 2016-06-30-5,082,003USD366
2014-07-01 to 2015-06-30-4,336,187USD365
2013-07-01 to 2014-06-30-4,588,218USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2016-06-3013,629,241USD
At 2015-06-3016,325,522USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2015-07-01 to 2016-06-30950USD366
2014-07-01 to 2015-06-302,214USD365
2013-07-01 to 2014-06-30883USD365

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2016-06-301,093,317USD
At 2015-06-301,092,194USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2016-06-30150,533USD
At 2015-06-30198,490USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2015-07-01 to 2016-06-305,211,157USD366
2014-07-01 to 2015-06-304,503,580USD365
2013-07-01 to 2014-06-304,391,747USD365

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2016-06-30334,395USD
At 2015-06-30403,955USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2016-04-01 to 2016-06-30-47,520USD91
2015-07-01 to 2016-06-30129,154USD366
2016-01-01 to 2016-03-3166,304USD91
2015-10-01 to 2015-12-3126,911USD92
2015-07-01 to 2015-09-3083,459USD92
2015-04-01 to 2015-06-30204,962USD91
2014-07-01 to 2015-06-30167,393USD365
2015-01-01 to 2015-03-3155,197USD90
2014-10-01 to 2014-12-31-37,964USD92
2014-07-01 to 2014-09-30-54,802USD92
2013-07-01 to 2014-06-30-196,471USD365

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2015-07-01 to 2016-06-30528,049USD366
2014-07-01 to 2015-06-30614,771USD365
2013-07-01 to 2014-06-30668,803USD365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2016-06-3055,010,619shares
At 2015-06-3054,967,559shares
At 2014-12-3138,419,502shares
At 2014-01-3141,540,982shares

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2016-06-308,117,818USD
At 2015-06-307,689,676USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2016-06-307,541,126USD
At 2015-06-307,114,836USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2016-06-30150,533USD
At 2015-06-30245,031USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2016-06-30303,734USD
At 2015-06-30263,597USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

PeriodValueUnitDays
At 2016-06-300USD
At 2015-06-300USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2015-07-01 to 2016-06-30-4,721,440USD366
2014-07-01 to 2015-06-30-3,691,683USD365
2013-07-01 to 2014-06-30-6,696,132USD365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2015-07-01 to 2016-06-303,786,657USD366
2014-07-01 to 2015-06-302,400,353USD365
2013-07-01 to 2014-06-302,488,219USD365

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2015-07-01 to 2016-06-30470,851USD366
2014-07-01 to 2015-06-30576,380USD365
2013-07-01 to 2014-06-30685,396USD365

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2015-07-01 to 2016-06-3080,938USD366
2014-07-01 to 2015-06-3025,226USD365
2013-07-01 to 2014-06-3018,468USD365

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2015-07-01 to 2016-06-30371,195USD366
2014-07-01 to 2015-06-30655,136USD365
2013-07-01 to 2014-06-30-1,370,904USD365

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2015-07-01 to 2016-06-300USD366
2014-07-01 to 2015-06-300USD365
2013-07-01 to 2014-06-3013,814,742USD365

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2015-07-01 to 2016-06-30-444,174USD366
2014-07-01 to 2015-06-30127,385USD365
2013-07-01 to 2014-06-30-24,723USD365

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2015-07-01 to 2016-06-3023,402USD366
2014-07-01 to 2015-06-30144,314USD365
2013-07-01 to 2014-06-30-45,834USD365

Inspect the source

Entity
PERSPECTIVE THERAPEUTICS, INC. / CIK 0000728387
Captured
2026-09-19T15:00:29.793Z
SEC response SHA-256
80792777921b49454c9d29f110283a1024ec5ce2a3749610d4c1319da49650fe

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000728387.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))